Torrent launches 'Rimoslim'

Ahmedabad, May 15 (UNI) Ahmedabad-based Torrent Pharma has launched 'Rimonabant', an anti-obesity molecule, for the first time in the country under the brand name 'Rimoslim' for India's rapidly multiplying obese population.

According to Ruchir Modi, Vice-President of Torrent Pharma, ''Rimoslim is vastly superior in the anti-obesity therapy segment'' and is priced at around Rs eight per tablet, making it an extremely affordable therapy for the masses.

''Rimoslim has undergone clinical trials in our research and development centre and the trial conducted on over 200 patients has shown encouraging results'', he said.

The market for anti-obesity products in India is growing at almost 50 per cent annually, given the increasing awareness about obesity and related complications.

Unlike other anti-obesity drugs, Rimoslim acts favourably on the lipid parameters and reduces Triglycerides and Haemoglobin A1C levels. It also increases HDL levels to help in managing the blood sugar levels, Modi added.

UNI